{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:44:17Z","timestamp":1787010257432,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:p>\n                    The\n                    <jats:italic toggle=\"yes\">RAD51D<\/jats:italic>\n                    gene codes a protein-paralog of the RAD51 DNA recombinase, which catalyzes DNA strand exchange during homologous recombination. Similar to\n                    <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                    \/\n                    <jats:italic toggle=\"yes\">BRCA2<\/jats:italic>\n                    , mutations in\n                    <jats:italic toggle=\"yes\">RAD51D<\/jats:italic>\n                    both predispose to ovarian carcinoma and impart sensitivity to poly (ADP-ribose) polymerase inhibitors in preclinical studies. Based on cancer risk prediction models,\n                    <jats:italic toggle=\"yes\">RAD51D<\/jats:italic>\n                    mutations pose a moderate-to-high risk for ovarian cancer warranting consideration for risk-reducing surgery. We report a case of serous tubal intraepithelial carcinoma in a patient undergoing risk-reducing total hysterectomy with bilateral salpingo-oophorectomy for a\n                    <jats:italic toggle=\"yes\">RAD51D<\/jats:italic>\n                    pathogenic variant. The histopathologic and p53-immunophenotypic features of this lesion are similar to those reported previously in\n                    <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                    \/\n                    <jats:italic toggle=\"yes\">BRCA2<\/jats:italic>\n                    mutation carriers and those of serous tubal intraepithelial carcinoma associated with sporadic high-grade serous carcinomas. These features include marked increase in nuclear-to-cytoplasmic ratio, loss of cell polarity, absence of ciliation, prominent nucleoli, mitotic activity, epithelial stratification, surface exfoliative changes, and complete loss of p53 staining. Although familial ovarian cancers with mutations in\n                    <jats:italic toggle=\"yes\">RAD51D<\/jats:italic>\n                    \u2014or other genes in the Fanconi anemia pathway\u2014are much less common those with\n                    <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                    \/\n                    <jats:italic toggle=\"yes\">BRCA2<\/jats:italic>\n                    mutations, our findings support a common phenotype for early serous cancers in this pathway.\n                  <\/jats:p>","DOI":"10.1097\/pgp.0000000000000857","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T21:01:06Z","timestamp":1644613266000},"page":"89-92","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Serous Tubal Intraepithelial Carcinoma in a Risk-reducing Salpingo-oophorectomy Specimen From a RAD51D Mutation Carrier: A Case Report"],"prefix":"10.1097","volume":"42","author":[{"given":"Kalin J.","family":"Gregory-Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura S.","family":"Colello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"McKinnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"key":"R1-20250802","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R2-20250802","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"R3-20250802","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-cancerbio-030617-050422","article-title":"The Fanconi anemia pathway in cancer","volume":"3","author":"Niraj","year":"2019","journal-title":"Annu Rev Cancer Biol"},{"key":"R4-20250802","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1101\/gad.947001","article-title":"Identification and purification of two distinct complexes containing the five RAD51 paralogs","volume":"15","author":"Masson","year":"2001","journal-title":"Genes Dev"},{"key":"R5-20250802","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/ng.893","article-title":"Germline mutations in RAD51D confer susceptibility to ovarian cancer","volume":"43","author":"Loveday","year":"2011","journal-title":"Nat Genet"},{"key":"R6-20250802","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1200\/JCO.2010.34.4440","article-title":"Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry","volume":"29","author":"Kurian","year":"2011","journal-title":"J Clin Oncol"},{"key":"R7-20250802","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/jnci\/djaa030","article-title":"Ovarian and breast cancer risks associated with pathogenic variants in RAD51C and RAD51D","volume":"112","author":"Yang","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"R8-20250802","doi-asserted-by":"crossref","first-page":"pky061","DOI":"10.1093\/jncics\/pky061","article-title":"Population frequency of serous tubal intraepithelial carcinoma (STIC) in clinical practice using SEE-Fim Protocol","volume":"2","author":"Samimi","year":"2018","journal-title":"JNCI Cancer Spectr"},{"key":"R9-20250802","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.humpath.2017.06.018","article-title":"Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and\/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2","volume":"70","author":"Schoolmeester","year":"2017","journal-title":"Hum Pathol"},{"key":"R10-20250802","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R11-20250802","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ygyno.2017.03.025","article-title":"Mortality reduction and cost-effectiveness of performing hysterectomy at the time of risk-reducing salpingo-oophorectomy for prophylaxis against serous\/serous-like uterine cancers in BRCA1 mutation carriers","volume":"145","author":"Havrilesky","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R12-20250802","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ygyno.2020.11.034","article-title":"Should the risk for uterine cancer influence decision making for prophylactic hysterectomy in BRCA1\/2 mutated patients- a systematic review and meta-analysis","volume":"160","author":"Nahshon","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R13-20250802","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","article-title":"Serous carcinogenesis in the fallopian tube: a descriptive classification","volume":"27","author":"Jarboe","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R14-20250802","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma\u2014evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J Pathol"},{"key":"R15-20250802","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/path.2624","article-title":"The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube","volume":"220","author":"Xian","year":"2010","journal-title":"J Pathol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:02:35Z","timestamp":1754161355000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000857","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,11]]}}}